IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATION: A Comparative Study of Combined Prophylaxis with CMV Hyperimmune Globulin Plus Ganciclovir Versus Ganciclovir Alone

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Transplantation

• Publication date

  2001-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-200111270-00012PMID 11726825
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantification of cytotoxic T-cell gene transcripts in human lung transplantation.

  2000cited by this paper
• Cytomegalovirus immune globulin intravenous (human) administration modulates immune response to alloantigens in sensitized renal transplant candidates

  2000cited by this paper
• Expression of Herpes Simplex Virus ICP47 and Human Cytomegalovirus US11 Prevents Recognition of Transgene Products by CD8+ Cytotoxic T Lymphocytes

  2000cited by this paper
• Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients

  1999cited by this paper
• Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

  1999cited by this paper
• Immunomodulatory actions of intravenous immunoglobulin (IVIG): potential applications in solid organ transplant recipients.

  1998cited by this paper
• Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation

  1997cited by this paper
• Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.

  1996cited by this paper
• Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors.

  1996cited by this paper
• Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group.

  1996cited by this paper
• Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.

  1996cited by this paper
• Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation.

  1995cited by this paper
• Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: evidence for a beneficial effect of hyperimmune globulin.

  1995cited by this paper
• Risk factors for survival following combined heart-lung transplantation. The first 100 patients.

  1994cited by this paper
• Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation

  1993cited by this paper
• Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy.

  1992cited by this paper
• A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.

  1992cited by this paper
• Cytomegalovirus infection and survival in lung transplant recipients.

  1991cited by this paper
• Intracoronary Ultrasound in Cardiac Transplant Recipients: In Vivo Evidence of “Angiographically Silent” Intimal Thickening

  1991cited by this paper
• A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

  1990cited by this paper
• Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.

  1989cited by this paper
• Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.

  1987cited by this paper

• Cytomegalovirus infections in thoracic organ transplant recipients: Updates on prevention, treatment, and immune monitoring

  2026cites this paper
• Twelve‐Month Clinical and Cost Outcomes of Removal of Cytomegalovirus Intravenous Immune Globulin From Heart Transplantation Protocol

  2025cites this paper
• The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

  2025cites this paper
• Real-Life Experience with Cytomegalovirus Hyperimmune Globulin in a Lung Transplant Unit: Long-Term Outcomes

  2025cites this paper
• Long‐Term Outcomes Among Lung Transplant Recipients With High‐Risk Cytomegalovirus Mismatch Managed With a Multimodality Regimen

  2025cites this paper
• Revisiting the Biological Rationale for Cytomegalovirus Immune Globulin (CMVIG) in the Modern Era of Solid Organ Transplantation: Current State and Future Direction.

  2025cites this paper
• Prevention of Cytomegalovirus Infection in Solid Organ Transplant Recipients: Guidelines by the Korean Society of Infectious Diseases and the Korean Society for Transplantation

  2024cites this paper
• Cytomegalovirus Infection is Associated with Impaired Myocardial Flow Reserve After Heart Transplantation.

  2023cites this paper
• Herpes Virus Infection in Lung Transplantation: Diagnosis, Treatment and Prevention Strategies

  2023cites this paper
• Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021

  2022cites this paper
• Cytomegalovirus

  2021cites this paper
• Use of anti‐CMV immunoglobulins in lung transplant recipients: The French experience

  2021cites this paper
• Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.

  2021cites this paper
• Use of Immunoglobulins in the Prevention of Viral Infections

  2021cites this paper
• Recent progress in development of monoclonal antibodies against human cytomegalovirus.

  2021cites this paper
• Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure

  2021cites this paper
• Prevention and therapy of viral infections in patients with solid organ transplantation.

  2020cites this paper
• La patologia da Citomegalovirus nel paziente portatore di trapianto renale: impatto, prevenzione e trattamento

  2019cites this paper
• Pediatric Lung Transplantation

  2019cites this paper
• The use of CMVIg rescue therapy in cardiothoracic transplantation: A single‐center experience over 6 years (2011‐2017)

  2019cites this paper
• Resource utilization of cytomegalovirus immune globulin in prevention and treatment of cytomegalovirus infection in pediatric heart transplantation

  2019cites this paper
• Practice variability in pediatric heart transplantation: opportunities for collaboration.

  2019cites this paper
• Intravenous immunoglobulin (IVIg) acts directly on conventional T cells to suppress T cell receptor signaling.

  2019cites this paper
• ESITRA-SEIMC / REIPI recommendations for the management of cytomegalovirus nfection in solid-organ transplant patients

  2019cites this paper
• The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis

  2019cites this paper
• Infektionen nach Nierentransplantation

  2018cites this paper
• Infections after lung transplantation.

  2018cites this paper
• Diminished impact of cytomegalovirus infection on graft vasculopathy development in the antiviral prophylaxis era – a retrospective study

  2018cites this paper
• Infection in Organ Transplantation

  2017cites this paper
• Infections After Cardiac Transplantation

  2017cites this paper
• Investigating and exploiting the latency-associated expression of the human cytomegalovirus gene US28 in early myeloid lineage cells.

  2017cites this paper
• Humoral responses to Cytomegalovirus glycoprotein B vaccine with MF59 adjuvant

  2017cites this paper
• Lung Transplantation-Related Pathology

  2017cites this paper
• Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection.

  2017cites this paper
• Lederman : Haemophilia , HIV and HIV pathogenesis Thrombosis and Haemostasis

  2017cites this paper
• Prevention of chronic rejection after lung transplantation.

  2017cites this paper
• Cytomegalovirus infection after solid organ transplantation

  2016cites this paper
• Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation

  2016influential citation
• Infections

  2016cites this paper
• Enfermedades Infecciosas y Microbiología Clínica

  2016cites this paper
• Imaging the Complications of Lung Transplantation.

  2016cites this paper
• Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

  2016cites this paper
• Risks and Epidemiology of Infections Associated with Ventricular Assist Devices and Heart Transplantation

  2016cites this paper
• Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.

  2015cites this paper
• T-cell inhibitory capacity of hyperimmunoglobulins is influenced by the production process.

  2014cites this paper
• Treatment of cytomegalovirus infections beyond acute disease to improve human health

  2014cites this paper
• Pulmonary Disease BoarD review manual Pulmonary infections in lung Transplant recipients

  2014cites this paper
• Drugs Specifically Approved for Transplant Indications

  2014cites this paper
• Late Infectious Disease after Organ Transplantation

  2014cites this paper
• CMV management in lung transplant recipients

  2014cites this paper
• Misdirected antibody responses against non-neutralizing epitopes on human Cytomegalovirus

  2014cites this paper
• The Transplanted Heart

  2013cites this paper
• Obliterans Syndrome? Are Heart-Lung Transplant Recipients Protected From Developing Bronchiolitis

  2013cites this paper
• The association between cytomegalovirus immune globulin and long‐term recipient and graft survival following liver transplantation

  2012cites this paper
• Recent developments on coronary microvasculopathy after heart transplantation: a new target in the therapy of cardiac allograft vasculopathy.

  2012cites this paper
• Enfermedades Infecciosas y Microbiología Clínica

  2012cites this paper
• Cytomegalovirus infection in solid organ transplantation.

  2012cites this paper
• Efficacia e sicurezza della profilassi anti-citomegalovirus rispetto alla strategia pre-sintomatica con valganciclovir in pazienti con trapianto di cuore trattati con everolimus o micofenolato

  2012cites this paper
• Bronchiolitis Obliterans Syndrome

  2012cites this paper
• [Prevention of cytomegalovirus disease in lung transplantation].

  2011cites this paper
• DNA Viruses (CMV, EBV, and the Herpesviruses)

  2011cites this paper
• Effect of CMV-immunoglobulins (cytotect biotest) prophylaxis on CMV pneumonia after lung transplantation.

  2011cites this paper
• Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives

  2011cites this paper
• DNA viruses (CMV, EBV, and the herpesviruses).

  2011cites this paper
• GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.

  2011cites this paper
• Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation.

  2011cites this paper
• The impact of CMV prevention on long‐term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database

  2011cites this paper
• [Prophylaxis of cytomegalovirus infection in heart transplantation].

  2011cites this paper
• CHAPTER 23 – Cytomegalovirus

  2011cites this paper
• Profilaxis de la infección por citomegalovirus en el trasplante de corazón

  2011cites this paper
• [Prevention of cytomegalovirus infection: preemptive therapy versus universal prophylaxis].

  2011cites this paper
• Использование внутривенных иммуноглобулинов в клинической практике

  2011cites this paper
• Pediatric Lung Transplantation

  2011cites this paper
• Cytomegalovirus and Development of Cardiac Allograft Vasculopathy: Evidences and Therapeutic Implications

  2010cites this paper
• Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis

  2010cites this paper
• The immunocompromised patient

  2010cites this paper
• Heart transplants in pediatric patients: viral infection as a loss predictor.

  2010cites this paper
• Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients.

  2010cites this paper
• Nosocomial Herpesvirus Infections

  2010cites this paper
• Viral infections in lung transplant recipients.

  2010cites this paper
• Cytogam ® Cytomegalovirus Immune Globulin Intravenous ( Human ) FDA-Approved Indication Prophylaxis of cytomegalovirus disease associated with transplantation of : • Kidney

  2010cites this paper
• Cytomegalovirus Infection in Transplantation

  2010cites this paper
• Strategies for managing cytomegalovirus in transplant recipients

  2010cites this paper
• Viral Infections in Lung Transplant Recipients

  2010cites this paper
• Comparison of higher dose and lower dose ganciclovir for cytomegalovirus prophylaxis in seropositive heart transplant recipients

  2010cites this paper
• Cytomegalovirus Immune Globulin Intravenous (Human)

  2010cites this paper
• The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

  2010cites this paper
• Cytomegalovirus Prevention and Long-Term Recipient and Graft Survival in Pediatric Heart Transplant Recipients

  2010cites this paper
• Introduction: disease overview and risk factors.

  2010cites this paper
• Delayed onset CMV disease in solid organ transplant recipients.

  2009cites this paper
• Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.

  2009cites this paper
• Hematologic complications of anti‐CMV therapy in solid organ transplant recipients

  2009cites this paper
• Managing complications following lung transplantation

  2009cites this paper
• Antifungal Management in Risk Groups: Transplant Recipients

  2009cites this paper
• Lung and heart-lung transplantation

  2009cites this paper
• Pharmacotherapy of post-transplant viral infections.

  2008cites this paper
• Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid: Different Formulations in Stable Renal Transplant Patients

  2008cites this paper
• Optimal Length of Valganciclovir Prophylaxis after Solid Organ Transplantation

  2008cites this paper
• Human Cytomegalovirus Latent Infection of Myeloid Cells Directs Monocyte Migration by Up-Regulating Monocyte Chemotactic Protein-11

  2008cites this paper
• Protein-1 Up-Regulating Monocyte Chemotactic byMyeloid Cells Directs Monocyte Migration Human Cytomegalovirus Latent Infection

  2008cites this paper